mTORC2 Deficiency in CD11c+ dendritic Cells Promotes Acute Kidney Injury
1Starzl Transplantation Institute, University of Pittsburgh School of Medicine, Pittsburgh
2Department of Urological Organ Transplantation, The Second Xiangya Hospital of Central South University, Changsha, China.
Meeting: 2018 American Transplant Congress
Abstract number: 5
Session Information
Session Name: Concurrent Session: Antigen Presentation / Allorecognition / Dendritic Cells
Session Type: Concurrent Session
Date: Sunday, June 3, 2018
Session Time: 2:30pm-4:00pm
Presentation Time: 2:30pm-2:42pm
Location: Room 4C-3
Introduction: The role of the mammalian/mechanistic target of rapamycin (mTOR) in the pathophysiology of renal ischemia-reperfusion injury (IRI) is poorly characterized; furthermore, the influence of dendritic cell (DC)-based alterations in mTOR signaling in IRI has not been investigated.
Methods: We evaluated activation of the mTORC1/2 pathway in sham-operated and post kidney IRI C57BL/6 mice. Ex vivo isolated bone marrow-derived mTORC2 deficient (Rictor-/-) or wild-type (WT) DC underwent hypoxia-reoxygenation and then were analysed by flow cytometry. Adoptive transfer of WT or Rictor-/- DC to C57BL/6 mice followed by unilateral renal IRI was used to assess their in vivo migratory capacity. Age- and gender-matched DC-specific Rictor-/- mice or littermate controls underwent bilateral renal IRI followed by assessment of renal function, renal DC metabolism, histopathology, and bio-molecular and cell infiltration analysis.
Results: Protein expression of phosphorylated S6K that is a downstream of mTORC1 was upregulated, but conversely, phosphorylated AktS473 that is a downstream of mTORC2 was decreased in whole kidney tissue in response to IRI. Rictor-/- DC expressed more CD80/CD86 but less programed death ligand-1 (PDL1) which was enhanced by hypoxia-reoxygenation, and also increased migration to the injured kidney. Following IRI, Rictor-/- DC mice developed higher serum creatinine, more severe histologic damage, and greater pro-inflammatory mRNA transcript profiles of IL-1β, IL-6 and TNF-α compared to littermate controls. After IRI challenge, Rictor-/- DC showed increased TNF-α production, but significantly reduced IL-10 secretion compared to WT DC. Renal Rictor-/- DC were glycolytically biased compared to WT DC under both basal and IRI conditions. A greater influx of both neutrophils and T cells was seen in Rictor-/- DC mice, in addition to CD11c+MHCII+CD11bhiF4/80+ renal DC, that expressed more CD86 but less PDL1.
Conclusions: These novel data suggest that mTORC2 signaling in renal DC negatively regulates acute kidney injury. Thus, DC-targeted elimination of Rictor enhances inflammatory and migratory responses to the injured kidney, highlighting the regulatory roles of both DC and Rictor in the pathophysiology of renal IRI.
CITATION INFORMATION: Dai H., Watson A., Fantus D., Peng L., Thomson A., Rogers N. mTORC2 Deficiency in CD11c+ dendritic Cells Promotes Acute Kidney Injury Am J Transplant. 2017;17 (suppl 3).
To cite this abstract in AMA style:
Dai H, Watson A, Fantus D, Peng L, Thomson A, Rogers N. mTORC2 Deficiency in CD11c+ dendritic Cells Promotes Acute Kidney Injury [abstract]. https://atcmeetingabstracts.com/abstract/mtorc2-deficiency-in-cd11c-dendritic-cells-promotes-acute-kidney-injury/. Accessed November 21, 2024.« Back to 2018 American Transplant Congress